"G(M2) Ganglioside" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glycosphingolipid that accumulates due to a deficiency of hexosaminidase A or B (BETA-N-ACETYLHEXOSAMINIDASES), or GM2 activator protein, resulting in GANGLIOSIDOSES, heredity metabolic disorders that include TAY-SACHS DISEASE and SANDHOFF DISEASE.
| Descriptor ID |
D005678
|
| MeSH Number(s) |
D09.400.410.420.025.475.400 D10.390.470.025.475.400 D10.570.877.360.025.475.400
|
| Concept/Terms |
G(M2) Ganglioside- G(M2) Ganglioside
- Ganglioside GM2
- GM2, Ganglioside
- Tay-Sachs Disease Ganglioside
- Ganglioside, Tay-Sachs Disease
- Tay Sachs Disease Ganglioside
|
Below are MeSH descriptors whose meaning is more general than "G(M2) Ganglioside".
Below are MeSH descriptors whose meaning is more specific than "G(M2) Ganglioside".
This graph shows the total number of publications written about "G(M2) Ganglioside" by people in this website by year, and whether "G(M2) Ganglioside" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "G(M2) Ganglioside" by people in Profiles.
-
Almanasra A, Havranek B, Islam SM. In-silico screening and microsecond molecular dynamics simulations to identify single point mutations that destabilize ?-hexosaminidase A causing Tay-Sachs disease. Proteins. 2021 11; 89(11):1587-1601.
-
Kirvan CA, Swedo SE, Kurahara D, Cunningham MW. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity. 2006 Feb; 39(1):21-9.
-
Hann RM, Evans JE, McCluer RH, Eterovic VA. Gangliosides in membranes from Torpedo electric organ. Lipids. 1996 Jun; 31(6):627-33.